Featured Series
A Video Summary of the Sessions from the Annual Neurology Meeting in Philadelphia
Understanding the condition and its effects is essential to patient care.
There are 1.8 million cases of acute PTH and 400,000 chronic PTH cases annually in the US civilian population. Here’s what you should know.
Sublingually delivered Parkinson's therapy moves to Phase II http://t.co/9l6DHBy351 http://t.co/cF8OxLKx4W
FDA has granted commercial clearance for Relaxis, the first non-pharmacological approach to help improve the quality of sleep in patients with primary Restless Leg Syndrome …
June 2014 — Inspire Medical Systems has received marketing approval from the FDA for its Inspire Upper Airway Stimulation (UAS) system. The device is an implantable…
The FDA has approved the first generic versions of Celebrex (celecoxib) capsules, a treatment for rheumatoid arthritis, osteoarthritis, short-term (acute) pain, and other co…
I vividly remember (as may many of our readers), taking two tablespoons of cod liver oil every morning in the winte…
Launched in January 2002, Practical Neurology strives to enhance quality of care and improve the daily operation of neurology practices. Each month, our experts explain the real-world significance of recent advances in neurologic science and offer step-by-step advice on how to overcome the clinical and business challenges neurologists face. Our straightforward, how-to articles give neurologists tools they can put into practice right away.
